(Q37956717)

English

Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

scientific article published on December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet? (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Christine E. Staatz

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

author name string

Susan E Tett

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

759-772

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Therapeutic monitoring of mycophenolate in transplantation: is it justified?

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients--a systematic review.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppre

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Evaluation of the practicability of limited sampling strategies for the estimation of mycophenolic acid exposure in Chinese adult renal recipients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Bayesian parameter estimation and population pharmacokinetics

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Time-dependent clearance of mycophenolic acid in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With Glomerulonephritis

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Pharmacogenetic influences on mycophenolate therapy

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

Mycophenolate blood level monitoring: recent progress

1 reference

https://api.crossref.org/works/10.2165%2F11596380-000000000-00000

21 January 2018

A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring for mycophenolic acid is value for (little) money

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling of individual pharmacokinetics for computer-aided drug dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/22087863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11596380-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37956717&oldid=2201113572"